APA

Vasanthakumar A., Davis J. W., Abunimeh M., Söderholm J., Zha J., Dumas E. O., Cohen D. E., Waring J. F. & Lagging M. (20181126). Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens. : PloS one.

Chicago

Vasanthakumar Aparna, Davis Justin W, Abunimeh Manal, Söderholm Jonas, Zha Jiuhong, Dumas Emily O, Cohen Daniel E, Waring Jeffrey F and Lagging Martin. 20181126. Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens. : PloS one.

Harvard

Vasanthakumar A., Davis J. W., Abunimeh M., Söderholm J., Zha J., Dumas E. O., Cohen D. E., Waring J. F. and Lagging M. (20181126). Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens. : PloS one.

MLA

Vasanthakumar Aparna, Davis Justin W, Abunimeh Manal, Söderholm Jonas, Zha Jiuhong, Dumas Emily O, Cohen Daniel E, Waring Jeffrey F and Lagging Martin. Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens. : PloS one. 20181126.